Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Company Intro
Aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. Learn about our pipeline.
Aclaris Therapeutics, Inc. Headquaters
640 Lee Road
Aclaris Therapeutics, Inc. Share price
14 Sep 2022 08:31 GMT
-0.59 (-3.41 %)
Aclaris Therapeutics, Inc. Market cap
Aclaris Therapeutics, Inc. # 200Biotechnology
Latest Aclaris Therapeutics, Inc. News
27 Mar 2023
Hidradenitis Suppurativa (HS) Treatment Market North ...
Aclaris Therapeutics Inc. Key Segments Profiled in the Hidradenitis Suppurativa (HS) Treatment Market Industry Survey. By Clinical Stages: Hurley Stage 1- Low...
27 Mar 2023
Aclaris Therapeutics to Participate in the H.C. Wainwright ...
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients...
27 Mar 2023
An analyst sees good growth prospects for Aclaris ...
Aclaris Therapeutics Inc. (NASDAQ: ACRS) stock fell -1.72% on Friday to $8.01 against a previous-day closing price of $8.15. With 0.93 million shares...
WMC Market Score
WMC Market to Revenue Score
Aclaris Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
|Company||Currency||Revenue||Expense||Profit||Market Cap||WMC Sector Score|
|Aclaris Therapeutics, Inc.||USD||$6,852||$51,049||$-64,183||$10,710B||200|
|Regeneron Pharmaceuticals, Inc.||USD||$9,197,600||$3,997,800||$4,003,800||$754,300B||1|
|Vertex Pharmaceuticals Incorporated||USD||$6,414,881||$2,617,257||$2,762,032||$713,610B||2|
|Alexion Pharmaceuticals, Inc.||USD||$6,261,601||$2,747,200||$681,800||$||3|
Company Search vs Top 4 Industry Competitors
Total Aclaris Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. Post vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. WMC Market Score Calculations
|Details||Revenue||Total Social Followers||Total Social Posts||Search Volume||Digital Footprint Size||Digital change (New Pages)||WMC Market Score|
|Aclaris Therapeutics, Inc.||0.07||2.53||0.00||0||0||0||1.14|
|Regeneron Pharmaceuticals, Inc.||100||25.50||16.15||22||0||0||28.52|
|Vertex Pharmaceuticals Incorporated||69.75||35.68||8.95||33||0||0||34.78|
|Alexion Pharmaceuticals, Inc.||68.08||100||100||22||0||0||100|
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge